Suppr超能文献

钾通道开放剂可加速表皮屏障的恢复。

Potassium channel openers accelerate epidermal barrier recovery.

作者信息

Denda M, Tsutsumi M, Inoue K, Crumrine D, Feingold K R, Elias P M

机构信息

Shiseido Research Center, 2-12-1 Fukuura, Kanazawa-ku, Yokohama 236-8643, Japan.

出版信息

Br J Dermatol. 2007 Nov;157(5):888-93. doi: 10.1111/j.1365-2133.2007.08198.x. Epub 2007 Oct 4.

Abstract

BACKGROUND

Maintenance of a competent permeability barrier in the face of external and internal stressors requires signals between the stratum corneum interface and the metabolic machinery in the underlying nucleated layers. For example, reductions in the ion gradients for Ca2+ after acute barrier disruption stimulate lamellar body (LB) secretion, a response required to restore barrier homeostasis. Although alterations in external K+ levels also regulate barrier recovery after acute insults, the mechanisms whereby K+ regulates barrier function remain unknown.

OBJECTIVES

To evaluate effects of regulators of K+ channels on barrier homeostasis in hairless mice.

METHODS

We tested a number of chemically different drugs that alter intracellular K+ levels. Results Single applications of either K+ channel openers (i.e. 1-EBIO, minoxidil, diazoxide) or the K+ ionophore, valinomycin, accelerated barrier recovery after acute insults to murine skin, paralleled by a reduction in intracellular K+ levels in cultured human keratinocytes. In contrast, applications of K+ channel blockers (i.e. gilbenclamide, dequalinium) delayed barrier recovery. Alterations in intracellular K+ regulated barrier homeostasis by either stimulating (reduced K+) or inhibiting (elevated K+) LB secretion. Finally, development of epidermal hyperplasia, a downstream consequence of barrier disruption, was also inhibited by agents that reduce intracellular K+ levels.

CONCLUSIONS

These results demonstrate that changes in K+ levels that can be presumed to occur after barrier disruption signal metabolic responses, i.e. LB secretion, which accelerates normalization of barrier function.

摘要

背景

面对外部和内部应激源时,维持有效的渗透屏障需要角质层界面与下方有核层中的代谢机制之间进行信号传递。例如,急性屏障破坏后Ca2+离子梯度降低会刺激板层小体(LB)分泌,这是恢复屏障稳态所需的反应。尽管外部K+水平的改变也会调节急性损伤后的屏障恢复,但K+调节屏障功能的机制仍不清楚。

目的

评估K+通道调节剂对无毛小鼠屏障稳态的影响。

方法

我们测试了多种化学性质不同的可改变细胞内K+水平的药物。

结果

单次应用K+通道开放剂(即1-EBIO、米诺地尔、二氮嗪)或K+离子载体缬氨霉素,均可加速急性损伤后小鼠皮肤屏障的恢复,同时培养的人角质形成细胞内K+水平降低。相反,应用K+通道阻滞剂(即格列本脲、地喹氯铵)会延迟屏障恢复。细胞内K+的改变通过刺激(降低K+)或抑制(升高K+)LB分泌来调节屏障稳态。最后,屏障破坏的下游后果——表皮增生的发展也受到降低细胞内K+水平的药物的抑制。

结论

这些结果表明,屏障破坏后可能发生的K+水平变化会引发代谢反应信号,即LB分泌,从而加速屏障功能的正常化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验